The Food and Drug Administration (FDA) said on Wednesday it is monitoring a potential safety issue involving Boston ...

The FDA said some of Boston Scientific ’s Endotak Reliance defibrillator wires can become calcified, which may stop the ...

The update covers devices used in procedures to implant the company’s Watchman heart device.

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston Scientific told customers that its Endotak Reliance defibrillation leads with ...

The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.

Boston Scientific (BSX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

The FDA has issued an alert about a potentially high-risk issue involving models of Boston Scientific’s Watchman Access Systems, which are used to provide vascular and transseptal access during ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.

Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...

Boston Scientific’s revenues rose from $18.4 billion in 2019 to $20.2 billion in 2022, driven by an uptick in total procedures after a decline during the pandemic period.